Ispire Technology Inc. - Common Stock (ISPR)

Sequential growth returned, and a major OEM deal is nearing close.

Ispire Technology (NASDAQ:ISPR) reported fiscal first-quarter revenue of $27.5 million, down 9.3% from a year earlier but up 3.2% from the preceding quarter, as management pointed to improving margins and progress on receivables alongside plans to expand production in Malaysia. The company posted a

Malaysia licenses enable production scaling amid inflection point.

Ispire Technology (NASDAQ:ISPR) said it is entering fiscal 2027 with higher quarterly revenue, a reduced operating cost base and new manufacturing licenses in Malaysia, while continuing to work through legacy receivables and pursue commercialization opportunities for its nicotine technology platform

Ispire (ISPR) Q3 2026 Earnings Transcript

Ispire (ISPR) Q2 2026 Earnings Call Transcript

Kennedy's HHS appointment, Trump's DEA pick, new fast-track meds, and global cannabis trends—this week reshapes the future of cannabis.

Join Women Grow Leadership Summit 2025 for 2 days of networking, advocacy and business opportunities in cannabis ft. Brittney Griner, Ricky Williams, etc.

This week in cannabis: DEA shake-up, contaminated cannabis in the Netherlands, and global market updates.

Key Takeaways: RLX’s third quarter revenue rose 52%, as its gross margin rose more than 3 percentage points to 27.2% following a regulatory crackdown in 2021 A year after expanding beyond its China base, international business accounted for more than half of the vaping company’s revenues in the third quarter

Ispire Technology Inc. and IKE Tech advance age verification tech aimed at preventing underage vaping, gaining FDA support.

Cannabis stocks rally on prediction of Trump descheduling marijuana; MSOS leads gains with a 15% surge, followed by Cronos at nearly 13%.

Ispire Technology Inc. (NASDAQ: ISPR), a company with a focus on innovations in vaping technology and precision dosing, reported on Monday first quarter 2025 results for the period ended on Sept. 30, 2024. Revenue totaled $39.3 million, representing a decrease of 8.2% year-over-year to $42.9 million due to lower U.S. product sales (by $8.1 million year-over-year), partially offset by growth in Europe and other regions (notably South Africa). Gross profit increased by 13.2% to $7.7 million from $6.8 million, with gross margin improving to 19.5% from 16%, driven by a shift toward higher-margin products. Net loss amounted to $5.6 million ($0.10 per share), compared to a net loss of $1.3 million ($0.02 per share) in the prior year's period.